The pHion Therapeutics Limited leadership team includes inventors and legal staff from both Queen's University Belfast and Uimmune LC.
We believe that the individuals behind pHion Therapeutics represent the best minds investigating non-toxic cell penetrating peptides. They stand ready to support numerous applications of RALA and RALA++.
Founder & Chief Executive Officer
Helen is the inventor of pHion's breakthrough delivery platform. Given her extensive knowledge of drug development, Prof. McCarthy has brought the RALA drug delivery system to the point where it is ready to for commercialization with a wide range of compounds.
Co-Founder & Commercial Director
Dave is an independent inventor and entrepreneur who has been working to develop non-RALA peptides for drug delivery. With his knowledge of the technology and the market Dave intends to make RALA the gold standard in drug delivery for the pharmaceutical industry.
Chief Operating Officer
Darach is an experienced commercial lawyer and former Spinout Manager at QUBIS (the spinout and investment arm of Queen's University Belfast). Darach has over 10 years experience advising startups and scale ups with a focus on IP licensing, company structures and collaboration.